Evolución del consumo de antidepresivos en el área de Zamora desde 1996 a 1999

Madero, Alfonso Díaz; Ferreras, Adela López; Díez, Mario Tomé; Aragón, Martín L. Vargas

doi:10.1016/s0212-6567(01)70385-x

Cited by 11 publications

(3 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Para este estudio se han utilizado las DDD establecidas en el Nomenclator Digitalis 19 , por considerarlo más completo y actualizado, ya que constan todos los fármacos comercializados en España con sus DDD y el origen o autor de estas 13 . Para todas las DDD figura como origen la Clasificación Anatómica Terapéutica Química, excepto para amineptina, oxitriptan, y trazodona que aparece como origen o autor el Insalud.…”

Section: Materials Y Metodosunclassified

“…Lo anteriormente expuesto unido a la comercialización de nuevos fármacos sin los efectos secundarios de los antidepresivos más clásicos, y el hecho de existir un estudio de estas características en el Área de Zamora desde 1996-1999 13 , nos ha llevado a realizar un estudio cuyo objetivo es describir la evolución del consumo extrahospitalario de antidepresivos en las áreas de salud de La Rioja y Zamora desde 1997 al 2001, analizar las diferencias del consumo y valorar el impacto de los nuevos fármacos en las dos áreas.…”

Section: Introductionunclassified

See 1 more Smart Citation

Evolución del consumo de fármacos antidepresivos en las áreas sanitarias de La Rioja y Zamora durante el período 1997-2001

Aparicio¹,

Díez²,

Madero³

2004

Rev. Esp. Salud Publica

View full text Add to dashboard Cite

Section: Materials Y Metodosunclassified

Section: Introductionunclassified

Evolución del consumo de fármacos antidepresivos en las áreas sanitarias de La Rioja y Zamora durante el período 1997-2001

Aparicio¹,

Díez²,

Madero³

2004

Rev. Esp. Salud Publica

View full text Add to dashboard Cite

“…In association with the current economic crisis, there has been an alarming increase of PC consultations for psychological distress [ 4 , 5 ]. It has been estimated that a quarter of patients who attend PC consultations have had a mental disorder in the previous year, in particular problems related to anxiety and/or depression [ 1 , 2 , 6 , 7 ]. In our multi-tiered public health system, around 85-90% of these patients are treated in PC settings [ 8 ].…”

Section: Introductionmentioning

confidence: 99%

Efficacy of a cognitive and behavioural psychotherapy applied by primary care psychologists in patients with mixed anxiety-depressive disorder: a research protocol

Jauregui

Ponte²,

Salgueiro

et al. 2015

BMC Fam Pract

View full text Add to dashboard Cite

BackgroundIn contrast with the recommendations of clinical practice guidelines, the most common treatment for anxiety and depressive disorders in primary care is pharmacological. The aim of this study is to assess the efficacy of a cognitive-behavioural psychological intervention, delivered by primary care psychologists in patients with mixed anxiety-depressive disorder compared to usual care.Methods/DesignThis is an open-label, multicentre, randomized, and controlled study with two parallel groups. A random sample of 246 patients will be recruited with mild-to-moderate mixed anxiety-depressive disorder, from the target population on the lists of 41 primary care doctors. Patients will be randomly assigned to the intervention group, who will receive standardised cognitive-behavioural therapy delivered by psychologists together with usual care, or to a control group, who will receive usual care alone.The cognitive-behavioural therapy intervention is composed of eight individual 60-minute face-to face sessions conducted in eight consecutive weeks. A follow-up session will be conducted over the telephone, for reinforcement or referral as appropriate, 6 months after the intervention, as required.The primary outcome variable will be the change in scores on the Short Form-36 General Health Survey. We will also measure the change in the frequency and intensity of anxiety symptoms (State-Trait Anxiety Inventory) and depression (Beck Depression Inventory) at baseline, and 3, 6 and 12 months later. Additionally, we will collect information on the use of drugs and health care services.DiscussionThe aim of this study is to assess the efficacy of a primary care-based cognitive-behavioural psychological intervention in patients with mixed anxiety-depressive disorder. The international scientific evidence has demonstrated the need for psychologists in primary care. However, given the differences between health policies and health services, it is important to test the effect of these psychological interventions in our geographical setting.Trial registrationNCT01907035 (July 22, 2013).

show abstract

Are they being used safely? A retrospective cross-sectional tertiary health care survey of selective serotonin reuptake inhibitors prescribing practice in Singapore

Xie

Tan

2005

Hum. Psychopharmacol. Clin. Exp.

View full text Add to dashboard Cite

show abstract

Evolución del consumo de antidepresivos en el área de Zamora desde 1996 a 1999

Cited by 11 publications

References 9 publications

Evolución del consumo de fármacos antidepresivos en las áreas sanitarias de La Rioja y Zamora durante el período 1997-2001

Evolución del consumo de fármacos antidepresivos en las áreas sanitarias de La Rioja y Zamora durante el período 1997-2001

Efficacy of a cognitive and behavioural psychotherapy applied by primary care psychologists in patients with mixed anxiety-depressive disorder: a research protocol

Are they being used safely? A retrospective cross-sectional tertiary health care survey of selective serotonin reuptake inhibitors prescribing practice in Singapore

Contact Info

Product

Resources

About